AIMS/HYPOTHESIS: Diabetes is known to reduce survival after myocardial infarction. Our aim was to examine whether diabetes is associated with enhanced cardiomyocyte apoptosis and thus interferes with the post-infarction remodelling process in myocardium in rat. METHODS: Four weeks after intravenous streptozotocin (diabetic groups) or citrate buffer (controls) injection, myocardial infarction was produced by ligation of left descending coronary artery. Level of cardiomyocyte apoptosis was quantified by TUNEL and caspase-3 methods. Collagen volume fraction and connective tissue growth factor were determined under microscope. Left ventricular dimensions were evaluated by echocardiography and planimetry. RESULTS: The number of apoptotic cardiomyocytes was equally high in diabetic and non-diabetic rats after 1 week from infarction. At 12 weeks after infarction the number of apoptotic cells was higher in the diabetic as compared to non-diabetic rats both in the border zone of infarction and in non-infarcted area. Correspondingly, left ventricular end diastolic diameter, relative cardiac weight, connective tissue growth factor-expression and fibrosis were increased in diabetic compared with non-diabetic rats with myocardial infarction. CONCLUSION/ INTERPRETATION: Sustained cardiomyocyte apoptosis, left ventricular enlargement, increased cardiac fibrosis and enhanced profibrogenic connective tissue growth factor expression were detected after myocardial infarction in experimental diabetes. Apoptotic myocyte loss could be an important mechanism contributing to progressive dilatation of the heart and poor prognosis after myocardial infarction in diabetes.
AIMS/HYPOTHESIS: Diabetes is known to reduce survival after myocardial infarction. Our aim was to examine whether diabetes is associated with enhanced cardiomyocyte apoptosis and thus interferes with the post-infarction remodelling process in myocardium in rat. METHODS: Four weeks after intravenous streptozotocin (diabetic groups) or citrate buffer (controls) injection, myocardial infarction was produced by ligation of left descending coronary artery. Level of cardiomyocyte apoptosis was quantified by TUNEL and caspase-3 methods. Collagen volume fraction and connective tissue growth factor were determined under microscope. Left ventricular dimensions were evaluated by echocardiography and planimetry. RESULTS: The number of apoptotic cardiomyocytes was equally high in diabetic and non-diabeticrats after 1 week from infarction. At 12 weeks after infarction the number of apoptotic cells was higher in the diabetic as compared to non-diabeticrats both in the border zone of infarction and in non-infarcted area. Correspondingly, left ventricular end diastolic diameter, relative cardiac weight, connective tissue growth factor-expression and fibrosis were increased in diabetic compared with non-diabeticrats with myocardial infarction. CONCLUSION/ INTERPRETATION: Sustained cardiomyocyte apoptosis, left ventricular enlargement, increased cardiac fibrosis and enhanced profibrogenic connective tissue growth factor expression were detected after myocardial infarction in experimental diabetes. Apoptotic myocyte loss could be an important mechanism contributing to progressive dilatation of the heart and poor prognosis after myocardial infarction in diabetes.
Authors: E Riva; G Andreoni; R Bianchi; R Latini; G Luvarà; G Jeremic; C Traquandi; L Tuccinardi Journal: Pharmacol Res Date: 1998-03 Impact factor: 7.658
Authors: A Saraste; K Pulkki; M Kallajoki; P Heikkilä; P Laine; S Mattila; M S Nieminen; M Parvinen; L M Voipio-Pulkki Journal: Eur J Clin Invest Date: 1999-05 Impact factor: 4.686
Authors: W P Thomas; C E Gaber; G J Jacobs; P M Kaplan; C W Lombard; N S Moise; B L Moses Journal: J Vet Intern Med Date: 1993 Jul-Aug Impact factor: 3.333
Authors: R Marfella; M D'Amico; C Di Filippo; E Piegari; F Nappo; K Esposito; L Berrino; F Rossi; D Giugliano Journal: Diabetologia Date: 2002-06-26 Impact factor: 10.122
Authors: Marilen Federico; Enrique L Portiansky; Leandro Sommese; Francisco J Alvarado; Paula G Blanco; Carolina N Zanuzzi; John Dedman; Marcia Kaetzel; Xander H T Wehrens; Alicia Mattiazzi; Julieta Palomeque Journal: J Physiol Date: 2017-03-02 Impact factor: 5.182
Authors: Cristiano Mostarda; Bruno Rodrigues; Alessandra Medeiros; Edson D Moreira; Ivana C Moraes-Silva; Patricia C Brum; Katia De Angelis; Maria-Cláudia Irigoyen Journal: Am J Transl Res Date: 2014-05-15 Impact factor: 4.060
Authors: Courtney L Williamson; Erinne R Dabkowski; Walter A Baseler; Tara L Croston; Stephen E Alway; John M Hollander Journal: Am J Physiol Heart Circ Physiol Date: 2009-12-04 Impact factor: 4.733
Authors: Kathleen E Dennis; Salisha Hill; Kristie L Rose; Uchechukwu K A Sampson; Michael F Hill Journal: Cardiovasc Pathol Date: 2013-04-06 Impact factor: 2.185
Authors: Omar Asghar; Ahmed Al-Sunni; Kaivan Khavandi; Ali Khavandi; Sarah Withers; Adam Greenstein; Anthony M Heagerty; Rayaz A Malik Journal: Clin Sci (Lond) Date: 2009-05 Impact factor: 6.124